Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,676 | -139,674 | -256,256 | -284,126 | -227,006 |
| Depreciation Amortization | -8,521 | -7,872 | 1,103 | -3,547 | -120 |
| Accounts receivable | -52,482 | -38,829 | -55,033 | -9,391 | -10,765 |
| Accounts payable and accrued liabilities | 14,622 | 1,057 | 1,704 | 3,189 | -1,923 |
| Other Working Capital | -54,097 | -29,577 | -58,136 | -6,353 | -27,276 |
| Other Operating Activity | 101,977 | 90,696 | 96,432 | 40,684 | 37,017 |
| Operating Cash Flow | $-73,177 | $-124,199 | $-270,186 | $-259,544 | $-230,073 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -322 | -269 | -778 | -325 | -267 |
| Purchase Of Investment | -739,679 | -415,269 | -759,209 | -224,575 | -755,629 |
| Sale Of Investment | 404,851 | 521,079 | 631,614 | 505,244 | 275,601 |
| Investing Cash Flow | $-335,150 | $105,541 | $-128,373 | $280,344 | $-480,295 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 567,508 | 17,810 | 455,159 | 11,519 | 664,177 |
| Financing Cash Flow | $567,508 | $17,810 | $455,159 | $11,519 | $664,177 |
| Beginning Cash Position | 149,517 | 150,365 | 93,765 | 61,446 | 107,637 |
| End Cash Position | 308,698 | 149,517 | 150,365 | 93,765 | 61,446 |
| Net Cash Flow | $159,181 | $-848 | $56,600 | $32,319 | $-46,191 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,177 | -124,199 | -270,186 | -259,544 | -230,073 |
| Capital Expenditure | -322 | -269 | -778 | -325 | -267 |
| Free Cash Flow | -73,499 | -124,468 | -270,964 | -259,869 | -230,340 |